홈 > 시장보고서 > 의료기기 > 체외진단

시장보고서

상품코드

1420992

이식 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Transplant Diagnostics Market (Screening: Pre-transplant Diagnostics and Post-transplant Diagnostics; and Technique: Molecular Assay and Non-molecular Assay) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

발행일: 2023년 12월 | 리서치사:

Transparency Market Research | 페이지 정보: 영문 295 Pages | 배송안내 : 2-10일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

이식 진단 시장 - 보고서의 범위

TMR의 세계 이식 진단 시장에 대한 보고서는 과거와 현재의 성장 동향과 2023년부터 2031년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻을 수 있는 기회를 조사했습니다. 이 보고서는 세계 이식 진단 시장의 수익을 제공합니다. 2017년부터 2031년까지의 기간 동안 2023년을 기준 연도로, 2031년을 예측연도로 간주합니다. 이 보고서는 또한 2023년부터 2031년까지 세계 이식 진단 시장의 복합 연간 성장률(CAGR%)을 제공합니다.

이 보고서는 광범위한 조사를 통해 작성되었으며, KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체를 인터뷰하는 1차 조사에서 대부분의 연구 활동이 이루어졌으며, 2차 조사에서는 주요 기업의 제품 문헌, 연례 보고서, 보도 자료, 그리고 이식 진단 시장을 이해하기 위한 관련 문서에 대한 참조를 포함합니다. 이식 진단 시장을 이해하기 위한 관련 문서 참조를 포함합니다.

시장 현황
2023년 시장 가치	12억 달러
2031년 시장 가치	23억 달러
CAGR	7.7%

이 보고서는 세계 이식 진단 시장의 경쟁 환경을 자세히 조사했습니다. 세계 이식 진단 시장에서 활동하는 주요 기업이 식별되고 각 기업은 다양한 속성 측면에서 프로파일링됩니다. 기업 프로파일, 재무 상태, 최근 동향 및 SWOT는 이 보고서에 소개된 세계 이식 진단 시장의 기업 속성입니다.

시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
- Bio-Rad laboratories, Inc.
- Qiagen NV
- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific, Inc.
- Becton, Dickinson and Company
- Ortho Clinical Diagnostics
- Immucor, Inc.
- Illumina, Inc.
- Siemens Healthineers(Siemens AG)
- Agilent Technologies

LSH 24.02.15

Transplant Diagnostics Market - Scope of Report

TMR's report on the global transplant diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transplant diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transplant diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the transplant diagnostics market.

Market Snapshot
Market Value in 2023	US$ 1.2 Bn
Market Value in 2031	US$ 2.3 Bn
CAGR	7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transplant diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transplant diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transplant diagnostics market.

The report delves into the competitive landscape of the global transplant diagnostics market. Key players operating in the global transplant diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transplant diagnostics market profiled in this report.

Key Questions Answered in Global transplant diagnostics Market Report:

What is the sales/revenue generated by transplant diagnostics across all regions during the forecast period?
What are the opportunities in the global transplant diagnostics market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Transplant Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global transplant diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global transplant diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transplant diagnostics market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Diagnostics Market

4. Market Overview

4.1. Introduction
- 4.1.1. Product Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Transplant Diagnostics Market Analysis and Forecast, 2017-2031

5. Key Insights

5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry

6. Global Transplant Diagnostics Market Analysis and Forecast, by Screening

6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Screening, 2017-2031
- 6.3.1. Pre-transplant Diagnostics
- 6.3.2. Post-transplant Diagnostics
6.4. Market Attractiveness, by Screening

7. Global Transplant Diagnostics Market Analysis and Forecast, by Technique

7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Technique, 2017-2031
- 7.3.1. Molecular Assay
- 7.3.2. Non-molecular Assay
- 7.3.3. 7.4 Market Attractiveness, by Technique

8. Global Transplant Diagnostics Market Analysis and Forecast, by Application

8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2017-2031
- 8.3.1. Solid Organ Transplantation
  - 8.3.1.1. Kidney
  - 8.3.1.2. Liver
  - 8.3.1.3. Heart
  - 8.3.1.4. Lungs
  - 8.3.1.5. Pancreas
  - 8.3.1.6. Small Bowel
- 8.3.2. Stem Cell Transplantation
8.4. Market Attractiveness, by Application

9. Global Transplant Diagnostics Market Analysis and Forecast, by Products & Services

9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Products & Services, 2017-2031
- 9.3.1. Reagents & Consumables
- 9.3.2. Instruments
- 9.3.3. Software & Services
9.4. Market Attractiveness, by Products & Services

10. Global Transplant Diagnostics Market Analysis and Forecast, by End-user

10.1. Introduction and Definitions
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017-2031
- 10.3.1. Hospitals & Transplant Centers
- 10.3.2. Research Laboratories
- 10.3.3. Others
10.4. Market Attractiveness, by End-user

11. Global Transplant Diagnostics Market Analysis and Forecast, by Region

11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017-2031
- 11.2.1. North America
- 11.2.2. Europe
- 11.2.3. Asia Pacific
- 11.2.4. Latin America
- 11.2.5. Middle East & Africa
11.3. Market Attractiveness, by Region

12. North America Transplant Diagnostics Market Analysis and Forecast

12.1. Introduction
- 12.1.1. Key Findings
12.2. Market Value Forecast, by Screening, 2017-2031
- 12.2.1. Pre-transplant Diagnostics
- 12.2.2. Post-transplant Diagnostics
12.3. Market Attractiveness, by Screening
12.4. Market Value Forecast, by Technique, 2017-2031
- 12.4.1. Molecular Assay
- 12.4.2. Non-molecular Assay
12.5. Market Attractiveness, by Technique
12.6. Market Value Forecast, by Application, 2017-2031
- 12.6.1. Solid Organ Transplantation
  - 12.6.1.1. Kidney
  - 12.6.1.2. Liver
  - 12.6.1.3. Heart
  - 12.6.1.4. Lungs
  - 12.6.1.5. Pancreas
  - 12.6.1.6. Small Bowel
- 12.6.2. Stem Cell Transplantation
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by Products & Services, 2017-2031
- 12.8.1. Reagents & Consumables
- 12.8.2. Instruments
- 12.8.3. Software & Services
12.9. Market Attractiveness, by Products & Services
12.10. Market Value Forecast, by End-user, 2017-2031
- 12.10.1. Hospitals & Transplant Centers
- 12.10.2. Research Laboratories
- 12.10.3. Others
12.11. Market Attractiveness, by End-user
12.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.12.1. U.S.
- 12.12.2. Canada
12.13. Market Attractiveness Analysis
- 12.13.1. By Screening
- 12.13.2. By Technique
- 12.13.3. By Application
- 12.13.4. By Products & Services
- 12.13.5. By End-user
- 12.13.6. By Country

13. Europe Transplant Diagnostics Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast, by Screening, 2017-2031
- 13.2.1. Pre-transplant Diagnostics
- 13.2.2. Post-transplant Diagnostics
13.3. Market Attractiveness, by Screening
13.4. Market Value Forecast, by Technique, 2017-2031
- 13.4.1. Molecular Assay
- 13.4.2. Non-molecular Assay
13.5. Market Attractiveness, by Technique
13.6. Market Value Forecast, by Application, 2017-2031
- 13.6.1. Solid Organ Transplantation
  - 13.6.1.1. Kidney
  - 13.6.1.2. Liver
  - 13.6.1.3. Heart
  - 13.6.1.4. Lungs
  - 13.6.1.5. Pancreas
  - 13.6.1.6. Small Bowel
- 13.6.2. Stem Cell Transplantation
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by Products & Services, 2017-2031
- 13.8.1. Reagents & Consumables
- 13.8.2. Instruments
- 13.8.3. Software & Services
13.9. Market Attractiveness, by Products & Services
13.10. Market Value Forecast, by End-user, 2017-2031
- 13.10.1. Hospitals & Transplant Centers
- 13.10.2. Research Laboratories
- 13.10.3. Others
13.11. Market Attractiveness, by End-user
13.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.12.1. Germany
- 13.12.2. U.K.
- 13.12.3. France
- 13.12.4. Italy
- 13.12.5. Spain
- 13.12.6. Rest of Europe
13.13. Market Attractiveness Analysis
- 13.13.1. By Screening
- 13.13.2. By Technique
- 13.13.3. By Application
- 13.13.4. By Products & Services
- 13.13.5. By End-user
- 13.13.6. By Country/Sub-region

14. Asia Pacific Transplant Diagnostics Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast, by Screening, 2017-2031
- 14.2.1. Pre-transplant Diagnostics
- 14.2.2. Post-transplant Diagnostics
14.3. Market Attractiveness, by Screening
14.4. Market Value Forecast, by Technique, 2017-2031
- 14.4.1. Molecular Assay
- 14.4.2. Non-molecular Assay
14.5. Market Attractiveness, by Technique
14.6. Market Value Forecast, by Application, 2017-2031
- 14.6.1. Solid Organ Transplantation
  - 14.6.1.1. Kidney
  - 14.6.1.2. Liver
  - 14.6.1.3. Heart
  - 14.6.1.4. Lungs
  - 14.6.1.5. Pancreas
  - 14.6.1.6. Small Bowel
- 14.6.2. Stem Cell Transplantation
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by Products & Services, 2017-2031
- 14.8.1. Reagents & Consumables
- 14.8.2. Instruments
- 14.8.3. Software & Services
14.9. Market Attractiveness, by Products & Services
14.10. Market Value Forecast, by End-user, 2017-2031
- 14.10.1. Hospitals & Transplant Centers
- 14.10.2. Research Laboratories
- 14.10.3. Others
14.11. Market Attractiveness, by End-user
14.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.12.1. China
- 14.12.2. Japan
- 14.12.3. India
- 14.12.4. Australia & New Zealand
- 14.12.5. Rest of Asia Pacific
14.13. Market Attractiveness Analysis
- 14.13.1. By Screening
- 14.13.2. By Technique
- 14.13.3. By Application
- 14.13.4. By Products & Services
- 14.13.5. By End-user
- 14.13.6. By Country/Sub-region

15. Latin America Transplant Diagnostics Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast, by Screening, 2017-2031
- 15.2.1. Pre-transplant Diagnostics
- 15.2.2. Post-transplant Diagnostics
15.3. Market Attractiveness, by Screening
15.4. Market Value Forecast, by Technique, 2017-2031
- 15.4.1. Molecular Assay
- 15.4.2. Non-molecular Assay
15.5. Market Attractiveness, by Technique
15.6. Market Value Forecast, by Application, 2017-2031
- 15.6.1. Solid Organ Transplantation
  - 15.6.1.1. Kidney
  - 15.6.1.2. Liver
  - 15.6.1.3. Heart
  - 15.6.1.4. Lungs
  - 15.6.1.5. Pancreas
  - 15.6.1.6. Small Bowel
- 15.6.2. Stem Cell Transplantation
15.7. Stem Cell Transplantation Market Attractiveness, by Application
15.8. Market Value Forecast, by Products & Services, 2017-2031
- 15.8.1. Reagents & Consumables
- 15.8.2. Instruments
- 15.8.3. Software & Services
15.9. Market Attractiveness, by Products & Services
15.10. Market Value Forecast, by End-user, 2017-2031
- 15.10.1. Hospitals & Transplant Centers
- 15.10.2. Research Laboratories
- 15.10.3. Others
15.11. Market Attractiveness, by End-user
15.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 15.12.1. Brazil
- 15.12.2. Mexico
- 15.12.3. Rest of Latin America
15.13. Market Attractiveness Analysis
- 15.13.1. By Screening
- 15.13.2. By Technique
- 15.13.3. By Application
- 15.13.4. By Products & Services
- 15.13.5. By End-user
- 15.13.6. By Country/Sub-region

16. Middle East & Africa Transplant Diagnostics Market Analysis and Forecast

16.1. Introduction
- 16.1.1. Key Findings
16.2. Market Value Forecast, by Screening, 2017-2031
- 16.2.1. Pre-transplant Diagnostics
- 16.2.2. Post-transplant Diagnostics
16.3. Market Attractiveness, by Screening
16.4. Market Value Forecast, by Technique, 2017-2031
- 16.4.1. Molecular Assay
- 16.4.2. Non-molecular Assay
16.5. Market Attractiveness, by Technique
16.6. Market Value Forecast, by Application, 2017-2031
- 16.6.1. Solid Organ Transplantation
  - 16.6.1.1. Kidney
  - 16.6.1.2. Liver
  - 16.6.1.3. Heart
  - 16.6.1.4. Lungs
  - 16.6.1.5. Pancreas
  - 16.6.1.6. Small Bowel
- 16.6.2. Stem Cell Transplantation
16.7. Market Attractiveness, by Application
16.8. Market Value Forecast, by Products & Services, 2017-2031
- 16.8.1. Reagents & Consumables
- 16.8.2. Instruments
- 16.8.3. Software & Services
16.9. Market Attractiveness, by Products & Services
16.10. Market Value Forecast, by End-user, 2017-2031
- 16.10.1. Hospitals & Transplant Centers
- 16.10.2. Research Laboratories
- 16.10.3. Others
16.11. Market Attractiveness, by End-user
16.12. Market Value Forecast, by Country/Sub-region, 2017-2031
- 16.12.1. GCC Countries
- 16.12.2. South Africa
- 16.12.3. Rest of Middle East & Africa
16.13. Market Attractiveness Analysis
- 16.13.1. By Screening
- 16.13.2. By Technique
- 16.13.3. By Application
- 16.13.4. By Products & Services
- 16.13.5. By End-user
- 16.13.6. By Country/Sub-region

17. Competition Landscape

17.1. Market Player - Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
- 17.3.1. Bio-Rad laboratories, Inc.
  - 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.1.2. Product Portfolio
  - 17.3.1.3. Financial Overview
  - 17.3.1.4. SWOT Analysis
  - 17.3.1.5. Strategic Overview
- 17.3.2. Qiagen N.V.
  - 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.2.2. Product Portfolio
  - 17.3.2.3. Financial Overview
  - 17.3.2.4. SWOT Analysis
  - 17.3.2.5. Strategic Overview
- 17.3.3. F. Hoffmann-La Roche AG
  - 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.3.2. Product Portfolio
  - 17.3.3.3. Financial Overview
  - 17.3.3.4. SWOT Analysis
  - 17.3.3.5. Strategic Overview
- 17.3.4. Thermo Fisher Scientific, Inc.
  - 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.4.2. Product Portfolio
  - 17.3.4.3. Financial Overview
  - 17.3.4.4. SWOT Analysis
  - 17.3.4.5. Strategic Overview
- 17.3.5. Becton, Dickinson and Company
  - 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.5.2. Product Portfolio
  - 17.3.5.3. Financial Overview
  - 17.3.5.4. SWOT Analysis
  - 17.3.5.5. Strategic Overview
- 17.3.6. Ortho Clinical Diagnostics
  - 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.6.2. Product Portfolio
  - 17.3.6.3. Financial Overview
  - 17.3.6.4. SWOT Analysis
  - 17.3.6.5. Strategic Overview
- 17.3.7. Immucor, Inc.
  - 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.7.2. Product Portfolio
  - 17.3.7.3. Financial Overview
  - 17.3.7.4. SWOT Analysis
  - 17.3.7.5. Strategic Overview
- 17.3.8. Illumina, Inc.
  - 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.8.2. Product Portfolio
  - 17.3.8.3. Financial Overview
  - 17.3.8.4. SWOT Analysis
  - 17.3.8.5. Strategic Overview
- 17.3.9. Siemens Healthineers (Siemens AG)
  - 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.9.2. Product Portfolio
  - 17.3.9.3. Financial Overview
  - 17.3.9.4. SWOT Analysis
  - 17.3.9.5. Strategic Overview
- 17.3.10. Agilent Technologies
  - 17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
  - 17.3.10.2. Product Portfolio
  - 17.3.10.3. Financial Overview
  - 17.3.10.4. SWOT Analysis
  - 17.3.10.5. Strategic Overview

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,795

￦ 8,182,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,418,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 16,654,000

※ 부가세 별도

이식 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2023-2031년)

Transplant Diagnostics Market (Screening: Pre-transplant Diagnostics and Post-transplant Diagnostics; and Technique: Molecular Assay and Non-molecular Assay) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

이식 진단 시장 - 보고서의 범위

목차

제1장 서문

제2장 전제조건과 조사 방법

제3장 주요 요약 : 세계 시장

제4장 시장 개요

제5장 주요 인사이트

제6장 세계 시장 분석과 예측 : 스크리닝별

제7장 세계 시장 분석과 예측 : 방법별

제8장 세계 시장 분석과 예측 : 용도별

제9장 세계 시장 분석과 예측 : 제품 및 서비스별

제10장 세계 시장 분석과 예측 : 최종사용자별

제11장 세계 시장 분석과 예측 : 지역별

제12장 북미 시장 분석과 예측

제13장 유럽 시장 분석과 예측

제14장 아시아태평양 시장 분석과 예측

제15장 라틴아메리카 시장 분석과 예측

제16장 중동 및 아프리카 시장 분석과 예측

제17장 경쟁 구도